Full Text View
Tabular View
No Study Results Posted
Related Studies
Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML)
This study has been completed.
Study NCT00822094   Information provided by Celator Pharmaceuticals

First Received on January 12, 2009.   Last Updated on February 20, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Acute Myeloid Leukemia
Additional conditions recognized in this trial
Leukemia
Leukemia, Myeloid
Leukemia, Myeloid, Acute
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
CPX-351
Intensive Salvage Therapy
Sponsors listed in this trial
Celator Pharmaceuticals
The Leukemia and Lymphoma Society


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services